Theratechnologies sinks on HIV drug setback

(Reuters) – Theratechnologies Inc shares plummeted more than 60 percent on Friday after the Canadian drugmaker said its European partner, Ferrer Internacional SA, was withdrawing a marketing application for its lead drug for HIV patients. The Spanish company’s decision to pull the European Medicines Agency application for tesamorelin, used to reduce excess abdominal fat in HIV-infected patients with lipodystrophy, was made after a health committee raised safety concerns. The injectible drug is already approved by the U.S. Food and Drug Administration, according to the company’s website. …
Sexual Health News Headlines – Yahoo! News